M. Ventura

发表

Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.

C. Nguyen, M. Andreola, V. Dollé, 2000, Journal of medicinal chemistry.

A promoter activity is present in the DNA sequence corresponding to the hepatitis C virus 5' UTR.

C. Staedel, S. Reigadas, A. Cahour, 2003, Nucleic acids research.

A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors†

J. Toulmé, C. Wychowski, C. Staedel, 2008, Nucleic acids research.

HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA.

M. Castroviejo, S. Reigadas, M. Ventura, 2001, European journal of biochemistry.

Hepatitis C virus genetic variability in 52 human immunodeficiency virus‐coinfected patients

D. Neau, J. Ragnaud, M. Dupon, 2003, Journal of medical virology.

Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort.

D. Neau, M. Dupon, F. Dabis, 2013, The Journal of infectious diseases.

An oligonucleotide complementary to the SL-B1 domain in the 3'-end of the minus-strand RNA of the hepatitis C virus inhibits in vitro initiation of RNA synthesis by the viral polymerase.

M. Andreola, S. Reigadas, L. Tarrago-Litvak, 2003, Virology.

Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro.

P. Bellecave, M. Andreola, L. Tarrago-Litvak, 2003, Oligonucleotides.

Two Crucial Early Steps in RNA Synthesis by the Hepatitis C Virus Polymerase Involve a Dual Role of Residue 405

N. Scrima, D. Harrus, S. Bressanelli, 2012, Journal of Virology.

Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors

C. Nguyen, M. Andreola, L. Tarrago-Litvak, 2001, Expert opinion on emerging drugs.

The two crucial early steps in RNA synthesis by Hepatitis C virus 1 polymerase involve a dual role of residue 405 2

N. Scrima, D. Harrus, S. Bressanelli, 2012 .

Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.

C. Nguyen, M. Andreola, V. Dollé, 2000, Journal of medicinal chemistry.

RNA synthesis is modulated by G-quadruplex formation in Hepatitis C virus negative RNA strand

C. Di Primo, J. Mergny, M. Andreola, 2018, Scientific Reports.

Cellular uptake of ODNs in HIV-1 human-infected cells: a role for viral particles in DNA delivery?

P. Bellecave, M. Métifiot, M. Andreola, 2007, Oligonucleotides.

DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.

J. Toulmé, C. Calmels, M. Andreola, 2001, Biochemistry.

Mutations of the SL2 dimerization sequence of the hepatitis C genome abrogate viral replication

C. Di Primo, M. Ventura, J. Plissonneau, 2015, Cellular and Molecular Life Sciences.

Direct evidence for RNA–RNA interactions at the 3′ end of the Hepatitis C virus genome using surface plasmon resonance

C. Di Primo, M. Ventura, C. Masante, 2013, RNA.

Identification of a structural element of the hepatitis C virus minus strand RNA involved in the initiation of RNA synthesis

C. Staedel, F. Darfeuille, M. Ventura, 2010, Nucleic acids research.

Template requirements and binding of hepatitis C virus NS5B polymerase during in vitro RNA synthesis from the 3′‐end of virus minus‐strand RNA

P. Bellecave, M. Ventura, S. Litvak, 2005, The FEBS journal.

Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication.

H. Fleury, P. Trimoulet, A. Cahour, 2008, The Journal of general virology.

Hijacking hepatitis C viral replication with a non-coding replicative RNA.

M. Ventura, T. Astier-Gin, E. Dumas, 2010, Antiviral research.

Ribozyme targeting of HIV-1 LTR.

M. Ventura, S. Saragosti, N. Franck, 1994, Biochemical and biophysical research communications.

Activation of HIV-specific ribozyme activity by self-cleavage.

M. Perricaudet, T. Ragot, M. Ventura, 1993, Nucleic acids research.

Activation of GCN2 upon HIV-1 infection and inhibition of translation

H. Fleury, A. Jaspart, C. Calmels, 2013, Cellular and Molecular Life Sciences.

Activation of GCN2 upon HIV-1 infection and inhibition of translation

H. Fleury, A. Jaspart, C. Calmels, 2013, Cellular and Molecular Life Sciences.

A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.

B. Roques, N. Morellet, C. Lenoir, 2002, Journal of molecular biology.

Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNALys3/RNA initiation complex.

M. Ventura, S. Litvak, S. Moreau, 2001, Antisense & nucleic acid drug development.

The guanine-quadruplex aptamer 93del inhibits HIV-1 replication ex vivo by interfering with viral entry, reverse transcription and integration

V. Parissi, M. Andreola, S. Reigadas, 2011, Antiviral therapy.

Traitement d'une infection par un virus a arn a une arn polymerase arn dependante

M. Ventura, S. Litvak, T. Astier-Gin, 2007 .

Mutations of the SL2 dimerization sequence of the hepatitis C genome abrogate viral replication

C. Di Primo, M. Ventura, J. Plissonneau, 2015, Cellular and Molecular Life Sciences.

Hepatitis C virus intragenomic interactions are modulated by the SLVI RNA structure of the core coding sequence.

M. Andreola, M. Ventura, L. Martin, 2017, The Journal of general virology.

The hepatitis C virus minigenome: a new cellular model for studying viral replication.

D. Lapaillerie, M. Ventura, T. Astier-Gin, 2007, Journal of virological methods.

Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions

H. Fleury, C. Nguyen, V. Dollé, 1999, Archives of Virology.

Endogenous Expression of an Anti-TAR Aptamer Reduces HIV-1 Replication

J. Toulmé, J. Rossi, D. Castanotto, 2006, RNA biology.

D. Neau, M. Dupon, F. Dabis, 2013, The Journal of infectious diseases.